The treatment of babesiosis.
S
S
Ranque
D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000191:economics / Q000627:therapeutic use*; D053626:Atovaquone; D017963:Azithromycin / Q000191:economics / Q000627:therapeutic use*; D001404:Babesiosis / Q000188:drug therapy*; D002981:Clindamycin / Q000627:therapeutic use; D016527:Drug Costs; D004359:Drug Therapy, Combination; D006801:Humans; D009285:Naphthoquinones / Q000191:economics / Q000627:therapeutic use*; D011803:Quinine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D002981:Clindamycin; D017963:Azithromycin; D011803:Quinine; D053626:Atovaquone